Literature DB >> 3056986

Association between coagulation factors VII and X with triglyceride rich lipoproteins.

J C de Sousa1, C Soria, M Ayrault-Jarrier, D Pastier, E Bruckert, J Amiral, G Bereziat, J P Caen.   

Abstract

The association between the concentration of different plasma lipoproteins and plasma factor VII (F VII) was analysed by isolating plasma very low density lipoprotein (VLDL), low density lipoprotein (LDL), and high density lipoprotein (HDL) lipoproteins and assessing their in vitro interaction with F VII by immunoenzyme assay using peroxidase labelled anti-factor VII immunoglobulins to determine whether F VII coagulant activity is prognostic for cardiovascular mortality. F VII bound to triglyceride rich lipoproteins, the fixation being stronger on chylomicrons and VLDL fractions than on LDL fractions. In our experiments HDL did not bind to F VII. The fixation of coagulation factor X (FX) tested by the same method is comparable with that of F VII. The nature of this fixation seemed to arise from hydrophobic interaction as calcium was not necessary and the use of Tween 20 inhibited the interaction. The binding of factors VII and X was increased when lipids were previously treated by phospholipase C and the interaction seemed to be completely dependent on the lipid part of the lipoproteins. Hyrophobic fixation is a possible mechanism of interaction of plasma lipoproteins and F VII and X, and it may be of importance in the covariance of triglyceride concentrations and the activity of vitamin K dependent coagulation factors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3056986      PMCID: PMC1141648          DOI: 10.1136/jcp.41.9.940

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Association between dietary fat intake and plasma factor VII coagulant activity--a predictor of cardiovascular mortality.

Authors:  G J Miller; J C Martin; J Webster; H Wilkes; N E Miller; W H Wilkinson; T W Meade
Journal:  Atherosclerosis       Date:  1986-06       Impact factor: 5.162

2.  [Demonstration of several antigens in the LDL fraction of human serum lipoproteins].

Authors:  B Maitrot; G Lastra; M Ayrault-Jarrier; J Polonovski
Journal:  Biochimie       Date:  1972       Impact factor: 4.079

3.  Studies on blood coagulation factor V. I. The interaction of salts of fatty acids and coagulation factors.

Authors:  M J Kahn; H C Hemker
Journal:  Thromb Diath Haemorrh       Date:  1969-12-31

4.  Monoclonal antibodies to low density lipoprotein used for the study of low- and very-low-density lipoproteins, in "ELISA" and immunoprecipitation technics.

Authors:  S Salmon; S Goldstein; D Pastier; L Theron; M Berthelier; M Ayrault-Jarrier; M Dubarry; R Rebourcet; B Pau
Journal:  Biochem Biophys Res Commun       Date:  1984-12-14       Impact factor: 3.575

5.  Solid-phase enzyme-immunoassay for detection of hepatitis B surface antigen.

Authors:  G Wolters; L Kuijpers; J Kacaki; A Schuurs
Journal:  J Clin Pathol       Date:  1976-10       Impact factor: 3.411

Review 6.  [Metabolism of lipoproteins].

Authors:  P Drouin; J M Antoine; J P Pointel; J Louis; G Debry
Journal:  Ann Endocrinol (Paris)       Date:  1983 Jan-Mar       Impact factor: 2.478

7.  Further evidence that activated factor VII is related to plasma lipids.

Authors:  P Y Scarabin; L Bara; M Samama; G Orssaud
Journal:  Br J Haematol       Date:  1985-09       Impact factor: 6.998

8.  A novel form of factor VII in plasma from men at risk for cardiovascular disease.

Authors:  K Dalaker; I Hjermann; H Prydz
Journal:  Br J Haematol       Date:  1985-10       Impact factor: 6.998

9.  Increased activity of vitamin K-dependent clotting factors in human hyperlipoproteinaemia - association with cholesterol and triglyceride levels.

Authors:  M Constantino; C Merskey; D J Kudzma; M B Zucker
Journal:  Thromb Haemost       Date:  1977-08-31       Impact factor: 5.249

10.  In vitro effect of phospholipase C from Bacillus cereus on tissue thromboplastin from different species.

Authors:  O Hetland; T L Janson; B Johnsen
Journal:  Thromb Res       Date:  1982-10-01       Impact factor: 3.944

View more
  10 in total

1.  Effects of different protein sources on plasminogen inhibitor-1 and factor VII coagulant activity added to a fat-rich meal in type 2 diabetes.

Authors:  Lene S Mortensen; Claus Thomsen; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2010-11-10

Review 2.  Pharmacological control of hypertriglyceridemia.

Authors:  G Franceschini; R Paoletti
Journal:  Cardiovasc Drugs Ther       Date:  1993-06       Impact factor: 3.727

3.  Effect of the factor VII R353Q missense mutation on plasma apolipoprotein B levels: impact of visceral obesity.

Authors:  Marie-Thérèse Berthier; Alain Houde; Jean Bergeron; Denis Prud'homme; Jean-Pierre Després; Marie-Claude Vohl
Journal:  J Hum Genet       Date:  2003-07-08       Impact factor: 3.172

Review 4.  Physical activity and lipoprotein lipid disorders.

Authors:  A Berg; I Frey; M W Baumstark; M Halle; J Keul
Journal:  Sports Med       Date:  1994-01       Impact factor: 11.136

5.  Identification of patients at high risk for adverse coronary events while awaiting routine coronary angioplasty.

Authors:  M Chester; L Chen; J C Kaski
Journal:  Br Heart J       Date:  1995-03

6.  High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C.

Authors:  J H Griffin; K Kojima; C L Banka; L K Curtiss; J A Fernández
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

7.  Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk.

Authors:  Fernanda A Orsi; Willem M Lijfering; Arnoud Van der Laarse; L Renee Ruhaak; Frits R Rosendaal; Suzanne C Cannegieter; Christa Cobbaert
Journal:  Clin Epidemiol       Date:  2019-07-22       Impact factor: 4.790

Review 8.  Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL).

Authors:  Jih-Kai Huang; Hsiang-Chun Lee
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

9.  Severe Hypertriglyceridemia as a Cause of Aortic Thrombus with Peripheral Embolic Complications.

Authors:  Maya S Safarova; Kamal Gupta
Journal:  Kans J Med       Date:  2022-08-22

10.  Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society.

Authors:  Henry N Ginsberg; Chris J Packard; M John Chapman; Jan Borén; Carlos A Aguilar-Salinas; Maurizio Averna; Brian A Ference; Daniel Gaudet; Robert A Hegele; Sander Kersten; Gary F Lewis; Alice H Lichtenstein; Philippe Moulin; Børge G Nordestgaard; Alan T Remaley; Bart Staels; Erik S G Stroes; Marja-Riitta Taskinen; Lale S Tokgözoğlu; Anne Tybjaerg-Hansen; Jane K Stock; Alberico L Catapano
Journal:  Eur Heart J       Date:  2021-12-14       Impact factor: 29.983

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.